Skip to main content

Prevalent and Incident Use of SGLT2 Inhibitors

    Basic Details
    Date Posted
    Status
    In progress
    Medical Product
    canagliflozin
    canagliflozin/metformin HCl
    dapagliflozin propanediol
    dapagliflozin/metformin HCl
    empagliflozin
    empagliflozin/linagliptin
    Description

    These reports examine the prevalent and incident use of six sodium-glucose cotransporter 2 (SGLT2) inhibitors in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on May 18, 2015 to 14 Data Partners; this report includes information from 14 Data Partners.

    Additional Details
    FDA Center
    CDER
    Time Period
    2013 - 2015
    Analysis Type
    Descriptive
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)